Women's health firm AccuBoost has won a contract for its mammography-guided noninvasive brachytherapy technology from Bon Secours Cancer Institute in Norfolk, VA.
AccuBoost's brachytherapy treatment is designed for patients with early-stage breast cancer, according to the company. It can be used as a boost to the tumor bed or as a monotherapy option for accelerated partial-breast irradiation (APBI).
![A 53-year-old patient (patient number four) with a recurrent pituitary adenoma with extension of a cystic component of disease to the medial temporal lobe apparent on MRI (contoured in blue), and extension of disease to the left sphenoid bone and orbital apex apparent on [68Ga]Ga-DOTA-TATE (contoured in yellow).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/pituitary-tumor.QGsEnyB4bU.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
